Literature DB >> 3817017

Human c-fos proto-oncogene mapped to chromosome 14, band q24.3-q31. Possibilities for oncogene activation by chromosomal rearrangements in human neoplasms.

A J Ekstrand, L Zech.   

Abstract

The human c-fos proto-oncogene was mapped by in situ hybridization to chromosome 14, band q24.3-q31. As a probe we used 3H-labelled mouse c-fos RNA transcribed in vitro by SP6-RNA-polymerase. Of a total of 40 grains on chromosome 14, 19 (47.5%) were located within the 14q24.3-q31 region (p much less than 0.001). Mechanisms for c-fos to gain transforming ability by a break in a critical part of the gene have recently been described. Thus there are several possibilities for chromosomal aberrations within the 14q24.3-q31 region to be responsible for c-fos deregulation and which may result in neoplastic growth. Such specific aberrations are found in a variety of human neoplasms.

Entities:  

Mesh:

Year:  1987        PMID: 3817017     DOI: 10.1016/0014-4827(87)90244-8

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  4 in total

1.  Distal trisomy 14q. II. Molecular study of the 14q32 locus in two cases of chromosome 14 rearrangements with partial duplication.

Authors:  G Keyeux; S Gilgenkrantz; G Lefranc; M P Lefranc
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

2.  Two polymorphisms of the FOS oncogene.

Authors:  M A Siewertsen; D F Barker; D W Cox
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

3.  Chromosomal localization of the gene for the human trifunctional enzyme, methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase.

Authors:  R Rozen; D Barton; J Du; D W Hum; R E MacKenzie; U Francke
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

4.  Correlation of c-fos protein expression with neuropeptide content in the lung of bronchial asthmatic rat.

Authors:  Haiyan Liu; Xudong Yang; Wei Hou
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.